Marketing-authorisation holder · Canada
Abri Pharmaceuticals Inc
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DICLOFENAC MISOPROSTOL75 mg + 200 mcg · Tablet (Enteric-Coated) | Diclofenac, Misoprostol | Canada | Cancelled | |
| DICLOFENAC MISOPROSTOL50 mg + 200 mcg · Tablet (Enteric-Coated) | Diclofenac, Misoprostol | Canada | Cancelled | |
| RIZATRIPTAN ODT10 mg · Tablet (Orally-Disintegrating) | Rizatriptan | Canada | Cancelled | |
| RIZATRIPTAN ODT5 mg · Tablet (Orally-Disintegrating) | Rizatriptan | Canada | Cancelled | |
| ZOPICLONE5 mg · Tablet | Zopiclone | Canada | Cancelled | |
| ZOPICLONE7.5 mg · Tablet | Zopiclone | Canada | Cancelled |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|